Ticker
PROKCompany Name
PROKIDNEY CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Capital Expenditure | Free Cash Flow | Net Cash Flow - Operations |
---|---|---|---|
6/30/2025 | $ 32.16M | $ -146.58M | $ -114.42M |
3/31/2025 | $ 29.68M | $ -150.98M | $ -121.3M |
12/31/2024 | $ 29.51M | $ -155.86M | $ -126.35M |
9/30/2024 | $ 5.57M | $ -133.14M | $ -127.56M |
6/30/2024 | $ 31.11M | $ -153.21M | $ -122.1M |
3/31/2024 | $ 34.17M | $ -132.89M | $ -98.72M |
12/31/2023 | $ 34.2M | $ -124.27M | $ -90.07M |
9/30/2023 | $ 32.93M | $ -113.38M | $ -80.45M |
6/30/2023 | $ 5.31M | $ 459.64M | $ 464.94M |
3/31/2023 | $ 1.61M | $ -89.23M | $ -87.62M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations - CapEx
(=) FCF
FCF for PROKIDNEY CORP is calculated as follows: CF - Operations [ $ -1.21M ] - CapEx [ $ 0 ]
(=) FCF [ $ -1.21M ]
Minimum
Dec 31, 2024
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 3.3K |
---|---|
min | $ -356.66M |
max | $ 390M |
average | $ 28.76M |
median | $ 461K |
std | $ 117.98M |